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Abstract
Background: Essentiality assays are important tools commonly utilized for the discovery of gene functions.
Growth/no growth screens of single gene knockout strain collections are also often utilized to test the predictive
power of genome-scale models. False positive predictions occur when computational analysis predicts a gene to be
non-essential, however experimental screens deem the gene to be essential. One explanation for this inconsistency is
that the model contains the wrong information, possibly an incorrectly annotated alternative pathway or isozyme
reaction. Inconsistencies could also be attributed to experimental limitations, such as growth tests with arbitrary time
cut-offs. The focus of this study was to resolve such inconsistencies to better understand isozyme activities and gene
essentiality.
Results: In this study, we explored the definition of conditional essentiality from a phenotypic and genomic
perspective. Gene-deletion strains associated with false positive predictions of gene essentiality on defined minimal
medium for Escherichia coli were targeted for extended growth tests followed by population sequencing and
transcriptome analysis. Of the twenty false positive strains available and confirmed from the Keio single gene
knock-out collection, 11 strains were shown to grow with longer incubation periods making these actual true
positives. These strains grew reproducibly with a diverse range of growth phenotypes. The lag phase observed for
these strains ranged from less than one day to more than 7 days. It was found that 9 out of 11 of the false positive
strains that grew acquired mutations in at least one replicate experiment and the types of mutations ranged from
SNPs and small indels associated with regulatory or metabolic elements to large regions of genome duplication.
Comparison of the detected adaptive mutations, modeling predictions of alternate pathways and isozymes, and
transcriptome analysis of KO strains suggested agreement for the observed growth phenotype for 6 out of the 9 cases
where mutations were observed.
Conclusions: Longer-term growth experiments followed by whole genome sequencing and transcriptome analysis
can provide a better understanding of conditional gene essentiality and mechanisms of adaptation to such
perturbations. Compensatory mutations are largely reproducible mechanisms and are in agreement with
genome-scale modeling predictions to loss of function gene deletion events.
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Background
The term essential has been used to define those compo-
nents of the cell that are required to sustain cell growth.
Defining the essential components of life in organisms
large and small has been a topic of great scientific inter-
est, and, on one extreme, there is a growing effort to
understand the basic principles of life by studying and
even synthesizingminimal organisms [1, 2]. Beyond under-
standing the basic genotype-phenotype connection of
life, studies of gene essentiality provide knowledge for
medical and industrial applications. Essential genes pro-
vide targets for antibacterial drug discovery. For exam-
ple, by carefully targeting an essential cell component
in a bacterium as virulent as Mycobacterium tubercu-
losis, we can strive to treat pathogenic bacterial infec-
tions in a targeted and rational manner while at the
same time avoiding harmful side-effects to the host
organism [3]. Strategic, logical drug design has become
increasingly important in the face of rising numbers
of antibiotic resistant pathogens [4–6]. Thus, research
studies of gene essentiality have become important
knowledge sources for the advancement of science and
medicine.
How do we go about defining the set of essential
genes for an organism? Increased availability of genome
sequences has led to detailed experimental and computa-
tional examination of gene functions at a genome scale in
several model organisms, including E. coli. A clear method
for studying gene essentiality is the systematic experi-
mental disruption of genes. One such study resulted in
a collection of 3985 single-gene deletion strains for the
K-12 derivative strain of E. coli BW25113 [7]. Other stud-
ies have utilized high-throughput transposonmutagenesis
as a tool for gene disruption and identification of all essen-
tial genome elements beyond protein-coding sequences
[8]. Beyond experimentally defining essential genes, com-
putational tools such as constraint-based modeling have
been used for predicting essential components of cells,
most applicably metabolic components [9].
Expanding knowledge of the cellular components con-
tributing to metabolism has allowed for the construction
of genome-scale models of metabolism. The compre-
hensive metabolic model for E. coli, iJO1366 contains
information related to 1366 metabolic genes and their
associated 2251 reactions. Such models can be used to
study bacteria from a whole-cell, systems biology per-
spective [10–12]. By removing genes from the model and
performing flux-balance analysis, predictions about gene
essentiality on defined growth media can be made. These
predictions can then be compared to experimental data
and provide insight into existing knowledge gaps when
inconsistencies are encountered [13]. In general, such
metabolic models have shown a high degree of accuracy
in predicting the effect of gene knockouts. The iJO1366
reconstruction showed an 89.8% accuracy in predicting
gene knockout growth/no growth behavior [10] and its
subsequent update the iML1515 reconstruction showed
a 93.4% accuracy [12]. Failure modes are referred to as
false negative or false positive predictions. False negative
predictions are inconsistencies that occur when a model
predicts a gene to be essential, but experiments show
the gene to be non-essential. This can occur when there
is missing knowledge regarding alternate pathways or
isozymes, as has been previously demonstrated [14]. False
positive (FP) predictions are inconsistencies that occur
when the model predicts a gene to be non-essential, but
experiments show the gene to be essential. Such instances
can be attributed to the inclusion of unrealistic reac-
tions in the model. They can also, however, be attributed
to flaws in the experimental data. For example, high-
throughput growth screens conducted in plate format are
often stopped after 24 or 48 h of growth [7, 15, 16]. These
screens might not capture those strains that are slower
to grow. Furthermore, it is also possible that the mod-
els predict growth that is not feasible without some form
of genetic change or adaptation, which adjusts regulation
of predicted growth enabling pathways. High-throughput
screens are rarely followed by whole genome sequencing
given the assumption that mutations are not accrued in
such a short period of time. Thus, growth that is accom-
panied by genetic change is not captured by such growth
screens.
Essentiality is widely accepted to be conditional [17, 18].
Although there is a large set of non-metabolic and
metabolic genes that are essential regardless of growth
environment (e.g., genes related to replication, tran-
scription, translation, co-factor biosynthesis, and cell
structure), many genes essential for growth in one envi-
ronment might not be essential in another, given a differ-
ent nutrient composition. However, essentiality may also
be discussed in evolutionary terms. Upon the removal
of an essential gene, it is possible that a short period of
adaptation is sufficient to activate a redundant pathway
or isozyme and enable growth. On the other hand, some
genes may be essential regardless of whether or not an
adaptive period is provided. Thus, we can also consider
a spectrum of essentiality that is related to adaptability.
This has been discussed and demonstrated in studies of
multi-copy suppression and adaptive laboratory evolution
[14, 19]. The extent of redundant pathways in E. coli is yet
to be fully elucidated; however, underground metabolism
and enzyme promiscuity have been shown to play criti-
cal roles in adaptation to new growth environments or in
response to genetic perturbation [14, 20, 21].
In this study, we utilize previously reported FP predic-
tions of essentiality [13] to identify gene-deletion strains
that may be considered ‘non-essential’ given a longer incu-
bation period. This study examines gene-deletion strains
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which can be isolated in pure culture in vitro and cat-
egorizes them into three categories (expanding on def-
initions previously used [17, 18]). First, if a knockout
(KO) strain cannot grow on a defined medium where
the wild type strain can grow, ‘conditional essentiality’
is established. Second, if a KO strain is able to grow
on the defined medium where the wild type strain can
also grow, ‘non-essentiality’ is established. Third, if a KO
strain does not initially grow on a defined medium, but
is able to grow given an adaptive period and the acqui-
sition of mutations, ‘non-essentiality with mutations’ is
established. Longer growth tests are followed by whole
genome sequencing, transcriptome analysis of selected
strains, and interpretation of any resulting mutations and
expression changes to determine the adaptive mecha-
nisms required for the rescue of the KO strains analyzed.
The results presented demonstrate a striking agreement
between model-predicted alternate isozymes/pathways
and observed mutations and shed light on the dynamics
of growth observed for various non-essential genes.
Results
Identifying gene targets
The genes explored in this study were chosen because of
essentiality discrepancies observed between in silico pre-
dictions and in vivo observations [13]. Such discrepancies
indicate areas for discovery or better understanding as
they point out differences between in vivo screens and
computations based on the collected wealth of knowl-
edge for a given organism [9]. These discrepancies were
previously identified as FP model predictions (instances
where the model predicts that a gene is non-essential, but
experimental studies have identified the gene as essential
in the particular growth environment). FP model pre-
dictions are believed to occur due to the inclusion of a
‘non-physiological’ model reaction such as an unrealistic
alternate isozyme or pathway. On the other hand, FP pre-
dictions may also occur if there are errors in experimental
calls of essentiality. It is possible that short-term high-
throughput growth screens could result in genes being
identified as essential when in actuality they require more
incubation time to display growth. In these cases, it is pos-
sible that the metabolic model annotation of an alternate
pathway or isozyme is correct and such a predicted alter-
nate pathways might not be sufficiently expressed prior
to a period of adaptation. This study examined the pos-
sibility that FP predictions are caused by experimental
limitations. Furthermore, the dynamics and mechanisms
behind a cell’s ability to still display reproducible and
robust growth during time frames longer than normal
wild-type growth profiles were also examined. This was
accomplished by performing more extensive growth anal-
ysis of FP genes identified for the E. colimetabolic model,
iJO1366. 38 genes previously identified as FP predictions
[13] were utilized as a starting point for this study (Fig. 1a,
Additional file 1). These were genes associated with FP
predictions in defined minimal media conditions.
Growth screens considering longer time scales
Extended growth tests were performed on FP associated
gene-deletion strains with the hypothesis that model-
predicted alternate pathways would rescue growth given
longer incubation. Of the 38 FP associated gene KO
strains identified as potential targets for long growth incu-
bations, 20 were available in the Keio collection and con-
firmed by PCR (polymerase chain reaction) (Additional
file 1). Comparison of 18 genes for which no Keio strains
existed to an essential gene dataset reported by a study
conducting transposon-directed insertion site sequencing
[22], confirmed that 15 of the unavailable Keio strains
were on account of gene essentiality on nutrient-rich
media (Additional file 1, Fig. 1a). Therefore, such gene
KO strains are very unlikely to be constructed by the
approach used in the Keio collection or any KO method
and these unavailable strains were not considered for the
longer growth tests explored in this study [7] (Fig. 1a). The
20 confirmed gene-deletion strains available (Additional
file 1) were grown in a pure culture rich nutrient unde-
fined medium (Luria-Bertani LB broth) and then used to
inoculate minimal medium for the extended growth test.
Growth of these 20 gene-deletion strains was monitored
periodically over the course of approximately two weeks
or until growth was observed. If growth was observed,
the culture was passed to fresh media to ensure that the
growth would persist and was not a by-product of residual
LB media. Nine strains did not grow during the extended
growth test and were classified as conditionally essen-
tial (not essential in LB, but essential for growth in the
minimal medium tested) (Fig. 1a, Additional file 1). For
the KO strains that did display growth, such long incu-
bation growth tests showed that eleven of the twenty
previously identified essential genes were actually non-
essential (Fig. 1, Table 1). To confirm the reproducibility
of these results, these eleven gene-deletion strains were
grown again in triplicate (with some strains tested more
than triplicates, up to nine biological replicates) and their
cell density monitored more closely to acquire a more
detailed view of their growth trajectories (Fig. 1b). These
eleven gene KO strains were the main focus of this work.
Growth experiments showed a great deal of fitness
diversity among the eleven gene-deletion strains (Fig. 1b,
Table 1). While four of the eleven KO strains (cysK,
metL, thrA, ubiE) showed reproducible growth to
their respective final cellular densities within the first 48 h
of incubation, the remaining strains displayed more vari-
ability in the time necessary to display growth. Further-
more, some replicates showed a range in growth dynamics
between replicate experiments, which is reflected in the
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Fig. 1 Project workflow and growth characterizations of false positive strains. a A workflow summarizing the sequence of analyses followed and
results from this study. A Keio gene KO collection strain was not available for approximately half of the corresponding false positive genes listed in
[13], most likely due to essentiality on rich growth media [22]. Of those strains that were viable in rich media and thus available for a longer growth
test, approximately half showed growth in minimal defined media. Those strains that grew were analyzed for mutations. Five false positive strains
showed mutations in all replicate experiments sequenced. Four strains showed mixed results, meaning that only some populations accrued
mutations. Two strains showed no mutations in any replicate samples. The nine strains that showed mutations in at least some populations were
further analyzed in the context of model-predicted alternate pathways and historical data. Six of these cases showed agreement with
model-predictions, two showed agreement with previous reports of multi-copy suppression [81], and mutation analysis for one case was not clearly
linked to either. b Growth curves of eleven Keio collection strains associated with false positive predictions in defined minimal media. Growth data
in terms of cellular density in grams of dry weight per Liter (gDW/L) is reported for the FP gene KO strains. Those strains that accrued mutations in all
replicate populations during this growth test are noted with small dashed lines. Those strains that showed mixed results, showing mutations in only
some populations, are noted with larger dashed lines. All Keio strains were grown in M9 minimal medium with glucose as the carbon source with
the exception of cysK and cysP which utilized a glycerol carbon source. Growth of the wild type strain in glucose and glycerol is also provided as
a point of reference (black and grey growth curves)
standard deviation of the mean time required to reach
at least half of the final density observed during these
growth tests (Table 1, Additional file 2). For example,
proB experiments showed a high degree of variability
between the three replicates tested. One replicate reached
its final density, near that of wild-type, around Day 4
whereas the other two replicates had reached half this
level around Day 6 (Fig. 1b). Several gene-deletion strains
also showed variability in the final density achieved.While
several strains such as thrA, cysK, and metL showed
typical growth trajectories similar to the wild type strain
(with longer lag phases), other strains such as carA,
metC, and ubiE displayed significantly slower growth
rates and reached approximately half of the final cell den-
sity observed for the wild type during the testing period.
We hypothesized that the diverse range of growth phe-
notypes observed could be attributed to differences in
adaptive mechanisms required for growth. This was fur-
ther studied by examining mutations acquired during the
growth experiments.
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Table 1 Strain details from growth characterizations
Keio strain Possible alternate Final cell density (gDW/L) Time to > half Mutations
genes/pathways *mean, Std. Dev., %RSD final density (Hrs) flask1
*mean, Std. Dev., %RSD population?
WT glucose - 1.0, <0.01, 0.2% 10, <1, <0.01% No
WT glycerol - 1.1, 0.04, 3% 12, <1, 0.04% No
ubiE Alternate growth using 0.43, 0.08, 20% 14, 1, 9% No
demethylmenaquinone1
cysK cysM2 1.0, 0.1, 10% 21, <1, <0.01% Variable
metL (thrA or lysC)2 1.0, 0.1, 9% 28, 2, 7% Variable
metC (tnaA ormalY)2, 0.28, 0.1, 50% 36, 9, 20% Variable
(malY, alr, fimE)3
thrA (metL or lysC)2 1.1, 0.1, 8% 43, <1, 0.04% Yes
carA (yahI or arcC or yqeA)2, 0.50, 0.2, 40% 58, 17, 30% Variable
(carB, ygiT, cho, yncK)3
cysP (modA +modB +modC)2 1.1, 0.1, 10% 65, <1, 0.2% No
proA argE2 1.1, 0.3, 20% 190, 26, 10% Yes
proB argE2 0.66, 0.3, 50% 83, 10, 10% Yes
ptsI galP2, (fucP, xylE, galE)3 1.1, 0.1, 10% 100, 5, 5% Yes
serB glyA2, (gph, hisB, ytjC)3 0.95, 0.2, 20% 110, 8, 7% Yes
1Evidence for this described in [64]. 2 In silico prediction, iJO1366 genome-scale model of metabolism [13]. 3Experimental multicopy suppression evidence [19]. *The data
used from triplicate experiments represented in Fig. 1b was used to calculate means, standard deviations (St. Dev.), and percent relative standard deviations (%RSD)
Mutation analysis driven by parallel evolution
The guiding principle formutation analysis was to identify
evidence of parallelism between replicate experiments at
the level of genesmutated to determine likely mechanisms
of adaptation. Parallel evolution at the gene-level has been
demonstrated to provide compelling evidence specific to
applied selection pressures [23, 24] or, for this study,
in response to genetic perturbations. Parallelism was
examined by first identifying key mutation events across
replicate experiments, such as multiple unique muta-
tions occurring within the same gene or multiple unique
mutations in linked metabolic genes and their regula-
tory elements (Table 2). The identification of even a sin-
gle mutation shared between two samples (i.e., replicate
experiments) at the gene level is highly unlikely (Fisher’s
exact test p-value < 0.005, Additional file 3). These key
mutation events were interpreted in the context of model-
predicted alternate isozymes and pathways or other
experimental studies to further frame potential adaptive
evolution events. Model-associated isozymes were iden-
tified by examining model gene-protein-reaction asso-
ciations and model-associated alternate pathways were
identified by examining those reactions associated with
alternate growth solutions (Table 1).
Following growth characterization experiments,
genomic DNA was sequenced. Samples were taken from
the first flask of growth in minimal medium and prepped
for whole genome sequencing (referred to as flask 1 pop-
ulations, see Materials and Methods) (Additional file 4).
In addition to flask 1 population sample sequencing, the
starting inoculation strain grown in nutrient-rich media
was sampled and sequenced as a reference for mutation
analysis (Additional file 5). It is of importance to note
that four starting strains isolated from the Keio collection
and grown in rich medium (carA, cysK, metC,
and ptsI) contained mutations prior to growth on the
defined minimal medium (Additional file 5). These base
mutations, possibly acquired during the construction of
these strains, might have been selected for during growth
on the nutrient rich medium and will be addressed later
on a case-by-case basis. Of the eleven gene-deletion
strains that grew during the long growth tests, two strains
(cysP andubiE) did not reveal any prevalent mutations
in the flask 1 populations that were sequenced and were
thus considered non-essential and actually ‘True Positive’
model predictions (Fig. 1a). Five (thrA, ptsI, serB,
proA, and proB) accrued prevalent mutations in all
flask 1 populations sequenced (occurring at a fraction of
the total population > 0.2 as determined by read-depth)
that were not present in the inoculating cultures (Table 2).
These strains that acquired mutations during growth
were considered non-essential with mutations (Fig. 1a).
Four strains (cysK, metC, metL, and carA) showed
mutations in some of the flask 1 populations sequenced
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Table 2 Flask 1 population mutations
Keio Exp. # Fraction Gene Protein change Perceived impact
strain population
thrA 4 0.58 metK N226S -
2 0.46 metK G235A -
2 0.23 metJ V46E *Reduce MetJ repression1
1 0.79 metJ/metB Intergenic (-211/-66) *Reduce MetJ repression1
3 - 117 genes 130 kbp, 1.2X GDA IncreasemetL expression
[rrlA-rrfB]
ptsI 4, 5 1.0, 0.82 ydhF G65S -
(1, 4, (1.0, 1.0, metK/galP Intergenic (+328/-96) *Reduce GalR repression2
5, 6) 0.36, 0.39)
5 0.25 metK/galP Intergenic (+333/-91) Reduce GalR repression2
3 1.0 metK/galP Intergenic (+334/-90) Reduce GalR repression2
6 0.57 metK/galP Intergenic (+339/-85) Reduce GalR repression2
3 1.0 crp T141P Global regulatory effects3
5 0.70 crp G142S Global regulatory effects3
6 0.59 crp G142D Global regulatory effects3
4 1.0 crp R143H Global regulatory effects3
1 1.0 crp A145V Global regulatory effects3
6 0.43 crp I187T Global regulatory effects3
7 1.0 96 genes 99 kbp, 2X GDA Affect cyaA expression
[rrsC-rrlA]
serB 1 0.67 hisL/hisG Intergenic (+41/-105) *Increase his operon expression4
5 0.43 yhaC/garK Intergenic (+653/+370) -
1 0.27 yhaC/garK Intergenic (+883/+140) -
6 0.88 hisR His tRNA (5/77 bp) Increase his operon expression4
2 0.82 hisR His tRNA (48/77 bp) Increase his operon expression4
4 0.92 hisR His tRNA (67/77 bp) *Increase his operon expression4
7 0.71 hisR His tRNA (72/77 bp) Increase his operon expression4
proA 2 1.0 proB 1 bp Del -
1 0.77 argD G282D Reduce ArgD activity
2 0.56 argD Del (772-774/1221 bp) Reduce ArgD activity
4 0.43 argD Q154* Reduce ArgD activity
3 0.34 argD G49R Reduce ArgD activity
proB 6, 7 0.83, 0.72 glnA F463L Reduce GlnA activity
5 0.86 glnA D187E Reduce GlnA activity
4 0.45 glnA G179C Reduce GlnA activity
4 0.23 glnA H172R Reduce GlnA activity
1 1.0 glnA G171S Reduce GlnA activity
2 0.86 glnA E156D Reduce GlnA activity
3 1.0 glnA S148F Reduce GlnA activity
carA 7 0.27 carA/ carB Intergenic (+2/-16) Increase carB expression
5 0.86 carB L11L -
3, 7 0.31, 0.81 rpoS E96* -
3, 7 1.0 508 genes 520 kbp, 2X GDA Increase carB expression
[insD6-insD1]
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Table 2 Flask 1 population mutations (Continued)
Keio Exp. # Fraction Gene Protein change Perceived impact
strain population
metC 4 0.55 malI 10bp Dup (227/1029 bp) Reduce MalI activity5
2 0.32 malI Q55* Reduce MalI activity5
3 0.55 malX Q529Q -
metL 2, 4 0.72, 0.38 rpoS L317R -
4 1.0 metB 1 bp Del (1144/1161 bp) -
cysK 1 1.0 2,062 genes 2.1 Mbp, 2X GDA Increase cysM expression
[insL3-insL1]
3 0.21 sspA/rpsI Intergenic (-10/+385) -
GDA abbreviation stands for genome duplication amplification event. 1Binding site recognition sites predicted in [26]. 2Evidence to support binding site in [31]. 3Information
regarding CRP global regulatory effects in [32–34]. 4Attenuator-model of regulation for histidine operon described in [44–47]. 5Information related to the MalI transcriptional
repressor in [38, 39]. *Perceived impact was further confirmed by RNA sequencing results (Fig. 3, Table 3)
and were considered non-essential with/without muta-
tions since it appeared that it was possible to attain
growth without mutations; however, it was possible that
mutations were below the detection criteria (occurring
at a fraction < 0.2) and the population is highly heteroge-
neous with many mutations or the mutational events are
outside the scope of the computational mutation identifi-
cation pipeline utilized (e.g., genome rearrangements). In
summary, those strains that showed prevalent mutations
in some or all population samples sequenced were con-
sidered non-essential with mutations, whereas those that
showed no mutations were considered non-essential and
actually True Positive predictions (Fig. 1a).
The nature of the mutations that were observed varied
in terms of structural or regulatory mutations. Regula-
tory mutations observed included mutations in intergenic
regions, transcription factors, tRNAs, as well as large
Table 3 Differential expression of alternate pathways/genes in
knockout strains compared to wild type (RNAseq Data)











thrA Exp.1, Flask 5,
Clone
metL 2.18 2.06E-7
thrA Exp.2, Flask 1,
Population
metL 1.13 3.48E-2
ptsI Exp.1, Flask 5,
Clone
galP 1.73 2.50E-2
ptsI Exp.3, Flask 1,
Population
galP 0.908 5.46E-1
serB Exp.1, Flask 5,
Clone
hisB 3.75 3.60E-11
serB Exp.4, Flask 1,
Population
hisB 3.28 2.36E-9
regions of genome amplification. Mutations were consid-
ered structural if they occurred within the coding region
of a metabolic gene. The following sections highlight the
diversity and extent of parallel mutation events observed
during these extended growth experiments.
Mutation enrichment in genetic elements linked to
predicted alternate pathways/isozymes
In order to elucidate the mechanism of adaptation for
the FP gene-deletion strains, key mutations were analyzed
in the context of model-predicted alternate pathways or
isozymes (Tables 1 and 2). The first few cases highlighted
were in excellent agreement with the model-predicted
alternate functional pathway. For the thrA and ptsI
strains, mutations were enriched in intergenic regions that
could be linked to model-predicted alternate isozymes
(metL) or pathways (galP) (Fig. 2a, b). ThrA is anno-
tated as a bifunctional aspartate kinase and homoserine
dehydrogenase. The metabolic model for E. coli, iJO1366,
listsMetL as an alternative bifunctional enzyme capable of
catalyzing the same reactions [10], which is also supported
by in vitro enzyme assays [25]. It was thus speculated that
the intergenic mutations betweenmetJ andmetB (Fig. 2a)
affect transcription of metL [26]. Furthermore, the muta-
tion within the coding region of metJ, the transcriptional
repressor for variousmet operon genes, was also proposed
to influence expression of metL. Lastly, in another inde-
pendent replicate, a genome duplication amplification was
also detected (Table 2) which included the metL gene and
was thus hypothesized to increase metL expression. RNA
sequencing data demonstrated that the predicted com-
pensating isozyme metL was indeed up-regulated in the
adapted thrA strains (Fig. 3a, b). The expression ofmetL
was significantly up-regulated in the Exp. 1, Flask 5 clone
assayed at an increase of 4.5X (log2(fold change) = 2.18)
(Table 3, Fig. 3a). This supported the hypothesis that the
metJ/metB intergenic mutation influenced expression of
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Fig. 2 Pathway maps related to thrA, ptsI, and serB false positive cases. Whole genome sequencing analysis revealed that for two out of three
of these cases the model prediction was in agreement with the observed utilized pathway as inferred from mutation analysis. The associated
gene-protein-reaction information for each case is highlighted. In a, the mutation results for thrA imply that MetL (highlighted in orange) is the
enzyme responsible for the isozyme activity as predicted. b Results for ptsI suggest that the predicted alternate pathway related to GalP is utilized
in the absence of PtsI. c Results for serB suggest that contrary to the predicted GlyA associated alternate pathway, HisB is responsible for rescuing
growth in the absence of SerB
metL (Table 2, Fig. 3a). The expression of metL was also
significantly up-regulated in the Exp. 2, Flask 1 population
assayed at an increase of 2.2X (log2(fold change) = 1.13)
compared to wild type (Table 3, Fig. 3b). This popula-
tion assayed possessed an internalmetJ mutation (Table 2,
Fig. 3b). Together, the mutation enrichment analysis and
RNA sequencing data supported the isozyme prediction
made by the metabolic model.
Another FP case for which mutations showed strong
agreement with model-predictions was ptsI (Fig. 2b).
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Fig. 3 RNA sequencing data for thrA and serB experiments support isozyme predictions and mutation analysis. Volcano plots display log2(fold
change) on the x-axis and -log10(p-adjusted value) on the y-axis for RNA sequencing data acquired for thrA and serB experiments. The log2(fold
change) and p-adjusted value data was acquired comparing the experimental condition expression data (biological duplicate replicates) to wild
type BW25113 expression data (biological duplicate replicates). Each dot in the plots corresponds to the differential expression data of a gene. Panels
A. and B. correspond to the data for thrA experiments and panels c and d correspond to the data for serB experiments. The vertical dashed lines
in each plot corresponds to the 2X fold change line in either direction (log2(fold change) = 1, -1) and the horizontal dashed line corresponds to the
0.05 p-adjusted value line (-log10(p-adjusted value) = 1.3). Highlighted in red in panels a and b are themetL andmetB genes, which are expressed in
the same operon. Of interest for the thrA experiments was the up-regulation of the predicted isozyme,metL. Highlighted in red in panels c and d are
his operon genes that were up-regulated in both serB experiments. Of particular interest was hisB expression, the predicted isozyme for serB
PtsI is part of the well-characterized phosphoenolpyru-
vate:sugar phosphotransferase system (PTSsugar) [27–29].
This system is responsible for the phosphorylation and
transport of various carbohydrate substrates including
glucose; however, E. coli contains an alternative system for
glucose transport and phosphorylation linked to galP in
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iJO1366 (Fig. 2b). GalP is a proton symporter involved in
galactose transport, but it has also been shown to trans-
port glucose in ptsG and ptsM mutants [30]. The muta-
tion evidence observed in the ptsI experiments in this
study was suggestive of D-glucose transport via the galP
alternate pathway, as predicted by iJO1366 model simu-
lations. Seven mutations were observed in the intergenic
region upstream of galP in five independent replicate
experiments (Table 2). Of these seven mutation events,
four were identical at the nucleotide level of mutation
(Table 2), thus demonstrating a high degree of parallel
evolution for these replicate experiments and implicat-
ing that these intergenic mutations played an important
role in adaptation to the ptsI perturbation. The likeli-
hood of getting the same mutation at the nucleotide level
in two independent samples is even less likely than at
the gene level (Fisher’s exact test P < 5e-06, Additional
file 3).The mutation event was suggested to be associated
with increased expression of galP via reduced repression
by the transcriptional repressor GalR based on binding
site analysis [31]. Other mutations observed across the
replicateptsI populations were in CRP (cyclic-AMP reg-
ulatory protein). Six unique crp mutations were observed
in five replicate experiments (Table 2). CRP is known
to regulate the transcription of approximately 100 genes,
including galP, and it is activated by binding cyclic-AMP
(cAMP) [32–34]. Thus, the mutations observed could be
linked to influencing the expression of galP. Furthermore,
RNA sequencing data showed that galP was up-regulated
in ptsI strains as compared to wild type. The expres-
sion of galP was significantly up-regulated in the Exp. 1,
Flask 5 clone assayed at an increase of 3.3X (log2(fold
change) = 1.73), and further increased 1.9X (log2(fold
change) = 0.908) in the Exp. 3, Flask 1 population ana-
lyzed. These increases in expression thus support the
observation that galP does play a role in providing an
alternate pathway for glucose transport in strains with-
out a functional PTS system (Table 3). It is of interest
to note, however, that a cyaA mutation was observed
in the Keio parent strain used to inoculate all experi-
ments and this is likely widespread in the Keio collection
(Additional file 5). The mutation observed was a seven
base-pair deletion leading to the truncation of the CyaA
(cyclic-AMP synthase) protein, reducing it from 848
amino acids to 485 amino acids. CyaA activity is impor-
tant for the activation of the regulator CRP [35, 36] and
it is thus likely that this deletion event influenced these
growth study results. A similar cyaA truncating mutation
was observed in an adaptive laboratory evolution study
focusing on the effects of removing ptsH, ptsI, and crr
PTS genes [37]. It is also possible that the cyaA muta-
tion could have resulted in a synthetic genetic interac-
tion with those mutations acquired during the adaptation
experiments.
The metC strains evaluated in the growth screen
protocol showed mutations in only some of the popu-
lations sequenced (Table 2, no mutations were detected
in Exp. 1). For metC, the model predicted that malY
could compensate for the gene-deletion. The metC pop-
ulations showed mutations in malI, a regulatory protein
that represses expression of malY [38, 39]. Thus, it was
hypothesized that the two mutations observed in inde-
pendent replicate experiments are likely responsible for
increasingmalY expression.
Mutation analysis for the remaining cases did not show
as clear of an agreement with model predictions. The
mutations observed in the carA strains did not agree
with the model-predicted alternate pathway; however, it
did suggest agreement with previous multi-copy suppres-
sion results associated with over-expression of carB [19]
(Table 1). One mutation observed in a carA population
was in the carA/carB intergenic region, suggesting a regu-
latory effect on the expression of carB. Another was a syn-
onymousmutation in the coding region of carB, indicating
possible selective pressure for the use of carB, even though
the protein sequence did not change. The synonymous
mutation observed was for the Leucine 11 position,
substituting the CUG codon with CUU. According
to codon usage frequencies for E. coli, the CUG codon
is in greater relative abundance (0.5) compared to
that of the CUU codon (0.1) [40]. Thus, the muta-
tion is not expected to improve translation efficiency
based on codon frequency. Alternatively, such muta-
tions could impact mRNA secondary structure and pos-
itively influence transcript levels, enzyme production,
or enzyme activity as has been previously reported
[41, 42]. Lastly, there was also a genome duplication event
observed in some of the replicate experiments which
included carB.
For the serB experiments, distinct protein-coding,
intergenic, and tRNA non-coding mutations were
observed that could be linked to increasing the expres-
sion and possibly the activity of an isozyme, HisB. This
isozyme relationship (i.e., hisB being an isozyme of
serB) was not included in the iJO1366 reconstruction;
alternatively, a pathway for L-serine biosynthesis linked
to glyA was predicted by modeling to suppress the serB
deletion (Table 1, Fig. 2c). Mutations observed in the
replicate experiments, however, did not appear to be
associated with the glyA alternate pathway (Table 2,
Fig. 2c). Looking further, previous work has shown that
plasmid over-expression of hisB, gph, and ytjC individ-
ually could rescue a serB KO strain [19]. Furthermore,
directed evolution experiments have identified mutations
in the corresponding enzymes (HisB, Gph, and YtjC) that
could improve the isozyme activities that rescue a serB
deletion [43]. One such mutation, a D57N HisB protein
change [43], was also observed in a flask 5 clonal sample
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(i.e., a clone taken after several generations of growth
of the starting strain) in this study (Fig. 2c, Additional
file 4).
Parallel mutations linked to the regulation of the
histidine operon were also observed in serB flask 1
populations (Fig. 2c). Previous work has supported an
attenuator model of regulation for the histidine operon
[44–47]. Transcription of the histidine operon is believed
to be dependent on the secondary structure of a lead
mRNA (intergenic region between hisL and hisG), which
is affected by the translation of a histidine-rich lead pep-
tide (hisL). One key mutation observed was found in
the hisL/hisG intergenic region of experiment 1 (Fig. 2c),
likely increasing transcription of histidine operon genes
(including HisB) by directly affecting the attenuator
region. Indeed, differential gene expression analysis of
RNA sequencing data for a serB strain containing this
mutation showed that his operon genes were signifi-
cantly up-regulated compared to wild type expression
(Fig. 3c). In particular, hisB expression showed a 13X
increase in expression (log2(fold change) = 3.75) com-
pared to wild type expression (Table 3). Four other
replicate experiments, however, accrued four distinct
mutations in hisR, a non-coding histidine tRNA (Table 2).
Specifically, three (out of four) of these mutations were
found in the acceptor-stem of tRNAHis (Additional file 6)–
a region of tRNA important for recognition by aminoacyl-
tRNA synthetases (aaRS) [48, 49] and for proper cleavage
of the pre-tRNA transcripts [50, 51]. Moreover, tRNAHis
position A71 interacts with multiple residues of Histidyl-
tRNA synthetase (HisRS) [48] and the A–>G (72/77nt)
mutation found in replicate 7 has been shown to decrease
the cleavage precision of pre-tRNAs by E. coli ribonu-
clease P [50]. Previous studies have demonstrated that
mature tRNAHis can attenuate the transcription of the
his operon genes [44–47]. Thus, the hisR mutations
observed in the replicate experiments in this work are
speculated to reduce the amount of mature tRNAHis
and its attenuator behavior upon the his operon by
decreasing the efficacy of pre-tRNAHis cleavage and
amino-acylation, allowing for increased HisB expression.
This proposed mechanism’s output of increased HisB
expression was supported by examination of RNA
sequencing data for a popultaion containing a hisR muta-
tion (Fig. 3d). Differential gene expression analysis showed
that the his operon genes were significantly up-regulated
in the serB population compared to wild type (Fig. 3d)
and hisB showed a 9.5X increase in expression (log2(fold
change) = 3.25) (Table 3). Overall, the highly repro-
ducible mutations observed in this study appear to be
linked to increasing expression and possibly the side-
activity of HisB, a histidinol phosphatase which can
also perform the phosphoserine phosphatase function of
SerB [43].
Structural mutations are indirectly linked to an
underground activity
The mutations observed in the proA and proB growth
screen experiments could not be directly linked to the
predicted alternate gene argE as in those FP cases pre-
viously discussed; however, analysis suggested that the
mutations found in neighboring genes around the argE
encoded reactions are indirectly related to the suppression
of a proA or proB deletion phenotype. ProA and ProB are
enzymes involved in the first two steps of proline biosyn-
thesis in E. coliK-12 (Fig. 4a). Previous work in Salmonella
typhimurium and E. coli strains [52–54] have suggested
that an underground activity of the ArgE enzyme in E.
coli, typically involved in the arginine biosynthesis path-
way, can catalyze the conversion of N-acetyl-L-glutamate-
5-semialdehyde to L-glutamate 5-semialdehyde (Fig. 4a)
[20]. This side activity of ArgE does not typically occur
at a significant enough level to rescue a proA/proB KO
strain unless a mutation in argD occurs. The proposed
mechanism of suppression is that a mutation inactivates
ArgD activity leading to sufficient build up of the N-
acetyl-L-glutamate-5-semialdehyde metabolite such that
the underground activity of ArgE becomes significant
[20, 54]. Thus, the four parallel mutation events in argD
observed in theproA replicate experiments are in agree-
ment with these prior reports (Table 2). One observed
mutation in this study was predicted to significantly affect
ArgD activity by interfering with substrate binding since
residues 283 and 284 have been identified as ligand bind-
ing residues and the mutation observed was of glycine 282
changing to aspartate. Other mutations observed in repli-
cate experiments included a three base-pair deletion and
introduction of an early stop codon (Fig. 4a), also likely to
reduce ArgD activity.
While the mutations observed in the proA experi-
ments seemed to agree with previous reports, mutations
observed in proB appeared to be novel, but still related
to the underground activity of ArgE. Eight mutations in
seven independent proB replicate experiments occured
in the coding region of glnA, a glutamine synthetase
encoding gene (Fig. 4a, Table 2).When themutated amino
acid residues are highlighted on a predicted GlnA pro-
tein structure (I-Tasser structure prediction [55]), they
appear to be clustered in two distinct regions of the
GlnA chain (Fig. 4b). The mutations do not appear to
be directly changing ligand-binding residues based on
analysis of corresponding ligand-binding residues of a
Salmonella typhimurium GlnA enzyme [56]. The muta-
tions appear to be in regions that are highly buried
and involved in chain-chain interactions of the homo-
dodecameric enzyme (Fig. 4b). These mutations are likely
to have some effect on GlnA enzyme activity. If GlnA
activity were reduced, it is suggested that a larger L-
glutamate pool could increase flux through the ArgABCE
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Fig. 4 Structural mutations observed in proA and proB experiments analyzed in relation to ArgE underground activity. aMetabolic pathway
maps related to proA and proB false positive cases. Both are involved in L-proline synthesis. Model simulations predict using an alternate
pathway related to arginine and ornithine synthesis to rescue a proA/proB deficient E. coli strain. Mutations were observed in the coding regions of
the metabolic genes argD and glnA. It is suggested that reduced flux through these enzymes increases flux through the ArgE associated
underground activity, thus increasing production of L-proline and allowing for cell growth. bMutation analysis in relation to the glutamine
synthetase (GlnA) protein structure. An I-Tasser-predicted protein structure is provided [55] and the amino acid residue associated with observed
glnAmutations in the proB populations are highlighted in red. Those residues associated with ligand binding based on the crystal structure of the
Salmonella typhimurium GlnA enzyme [56] are highlighted in blue. The mutations appear to be in buried regions of the homo-dodecameric enzyme
at the interface of chain-chain interactions
pathway (Fig. 4a) and suppress the proB deletion. It is also
of interest to note that there were apparent differences
in growth fitness among three replicate growth curve
experiments as seen in Fig. 1b and Additional file 2. The
D187E mutation observed in Exp. 5 appeared to result
in significantly greater fitness compared to the F463L
mutations observed in Exps. 6 and 7 (Additional file 2,
Table 2). These two mutations lie in distinct regions of
the GlnA chain (Fig. 4b). In summary, mutation analysis
for the proA and proB experiments suggested distinct
adaptive mechanisms indirectly related to the low-level,
underground activity of the ArgE enzyme. This alternate
pathway is in agreement with model predictions made
with iJO1366.
Genome amplification events
A mechanism of adaptation observed in several gene
KO growth experiments was genome amplification. This
type of adaptation was observed most clearly in some
of the cysK, ptsI, and carA replicate experiments.
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Examination of the functional significance of these large
duplication events is statistically less compelling com-
pared to small mutation events (Fisher’s exact test result-
ing in larger p-values depending on size of duplication,
Additional file 3). However, although these large regions
of amplification often contain hundreds of genes, their
impact can sometimes be linked to a key gene of inter-
est [14, 57, 58]. The largest duplication observed was
in a cysK flask 1 population (Table 2). CysK is a
PLP-dependent enzyme involved in L-cysteine biosyn-
thesis and has been annotated as a cysteine synthase
and L-cysteine desulfhydrase [59, 60]. There are mul-
tiple cysteine-desulfhydrases suspected for E. coli K-12
including cysM, metC, tnaA, and malY [61]. CysM was
the isozyme listed in iJO1366 and predicted to rescue
a cysK KO strain. Mutations in the flask 1 population
sample for the cysK KO strain did not reveal any clear
key small mutations; however, a large region of genome
amplification of 2X multiplicity was observed based on
read-depth analysis (Additional file 7). The region span-
ning approximately 2 million basepairs, or slightly less
than half of the genome, does contain the gene encoding
the model-predicted alternate isozyme, cysM. The region
of amplification was flanked by IS186 insertion elements
(Additional file 7). It is proposed that these repetitive IS
element sequences were instrumental in the mechanism
of duplication by recombination as has been previously
described [57]. Although cysM was included within the
large region of amplification, further follow-up studies
conducting expression and/or KO analysis are required
in order to make more definitive claims of the alternate
pathway used to compensate for the cysK gene deletion.
Two instances of genome duplication occurred in
replicate experiments of carA and ptsI (Additional
file 7b, c). For the carA populations, a region of approx-
imately 520 kilo base pairs was duplicated in two replicate
experiments (Table 2). This region of amplification was
flanked by IS2 insertion elements. The region that was
amplified does include the carB gene that has been shown
to suppress a carA gene deletion in previous work [19]
(Fig. 4b). Thus, similar to the cysK case, the repetitive IS2
element seems to mediate the amplification and increased
dosage of the enzyme encoded by carB (Fig. 4b). Unlike
the cysK and carA genome amplification events, the ptsI
amplification was significantly smaller (99 kilo base pairs)
and flanked by genes encoding ribosomal RNA (rrlC and
rrsC on one side and rrlA and rrsA on the other) (Fig. 4c).
The gene pairs rrlA and rrlC, and rrsA and rrsC each
share 99% sequence identity according to BLAST (basic
local alignment search tool) alignment analysis [62]. Thus,
these repetitive sequence regions are potential targets
for duplication by recombination as is observed with IS
elements [57]. Although this region did not contain the
model-predicted gene of interest, galP, it did contain the
gene cyaA, which encodes an adenylate cyclase. Adeny-
late cyclase is responsible for the synthesis of cyclic AMP,
which is an important signaling molecule, and as previ-
ously mentioned, important for activation of the regulator
CRP [34–36]. Thus, this amplification appeared to be
indirectly related with affecting expression/regulation
of galP.
FP strains requiring nomutations for growth, or, true
positives
For those strains that did not acquire detectable muta-
tions during the long growth experiments, ubiE and
cysP, it is assumed that only regulatory responses were
required to shift expression of alternate metabolic path-
ways and enable growth. For the case of ubiE, however,
the drastic reduction in final cell density observed in
replicate experiments suggests that the associated reac-
tions involved in ubiquinone and menaquinone biosyn-
thesis are important for cellular energetics [63]. Previous
work has shown that ubiE mutant strains can grow using
demethylmenaquinone as the sole respiratory quinone
[64]. Although reported to be important during anaero-
bic growth, demethylmenaquinone was observed to have
a small but significant capacity to function during aer-
obic growth as well [65]. Furthermore, previous high
throughput growth screens show inconsistencies in label-
ing ubiE as essential, probably due to cell density cut-
offs utilized to label growth/ no growth [7, 12, 66]. Overall,
the results of this study (Fig. 1b, Table 1) are consistent
with prior reports and show that ubiE is non-essential for
growth on glucose minimal medium. For the case of cysP,
it is possible that the predicted alternate pathway (Table 1)
could be used to enable growth and only regulatory shifts
already wired in the wild-type strain are required. Detailed
analysis of these regulatory shifts were not pursued in
this study; however, future work could examine expres-
sion (RT-qPCR, RNAseq) of model-predicted alternate
pathways, following workflows similar to those previously
reported [14]. These cases are no longer considered FP
model predictions, but instead were true positive predic-
tions in agreement with the model.
Discussion
This study utilized a systematic model-driven approach
to identify genes that were mistakenly labeled as essen-
tial in minimal media, as well as interpret and suggest
mechanisms of adaptation to such genetic perturbations
when combined with growth experiments, whole genome,
and transcriptome sequencing. Three key findings were
supported by the results. Firstly, extended growth tests
of gene KO strains were shown to result in the rever-
sal of several calls of essentiality, in agreement with
model predictions. This finding has direct implications to
high-throughput screens of essentiality. Secondly, it was
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demonstrated that mutation events are likely even after
relatively short incubation times in response to genetic
perturbations. Finally, results showed that analysis of par-
allel mutation events among replicate experiments have
implications for expanding gene-protein-reaction associ-
ations in both knowledge bases and models.
Growth/ no growth calls made by large-scale growth
screens of gene-deletion strain collections such as the
Keio collection [7] serve as a comprehensive guide for
strain are key to testing the predictive power of genome-
scale metabolic models [13, 67]. Cellular acclimation
to such genetic and metabolic disruptions may require
greater time to make such growth/no growth calls as
mechanisms of adaptation or regulatory responses might
be required for detectable growth. Extended growth incu-
bation of FP KO strains in this study revealed that 55%
(11 out of 20) of the FP strains available and confirmed
could be considered true positives (both experiments and
predictions in agreement with calls of non-essentiality).
Growth of the examined FP KO strains was repro-
ducible, the degree of which is outlined in Table 1, given
growth conditions that were well-aerated and provided
sufficient time to allow for extended lag-phases. Thus,
this study outlines a quantitative time window in which
high-throughput growth screens can be designed to call
growth/no growth phenotypes going forward [7, 66, 68].
There was a great deal of phenotypic diversity observed
for the different KO strains that grew sub-optimally (as
compared to wild type) and this diversity is manifested
in the different mechanistic responses of the cells as
revealed through mutations. This wide range in growth
fitness demonstrates that essentiality screens for binary
growth/no growth do not provide a complete view of a
more general contribution to fitness. The idea of apply-
ing a ‘fitness index’ to each gene has been demonstrated
previously [69] and may allow for a more quantifiable
metric of contribution to growth fitness. Furthermore,
the nine strains which were confirmed as FPs and were
conditionally essential under these conditions are either
likely truly unable to grow under the conditions, or could
require more complex adaptation (i.e., mutations) to acti-
vate alternative pathways. Such efforts could be explored
using many more replicates, engineered hypermutating
strains, or by introducing a significant number of muta-
tions to a given strain prior to a growth test with a method
such as UV mutagenesis [70]. Alternatively, the model
could indeed contain ‘non-physiological’ reactions and
this set of nine cases provides a focused set of strains to
explore such events, in detail [71]. Lastly, the three genes
not in the Keio collection set or confirmed using the out-
lined PCR validation, aroE, entD, and waaU, which were
also not deemed essential on rich media [22] could be
attempted to be constructed and put through the same
workflow established in this work.
Coupling population sequencing with extended growth
tests in this study revealed that mutation events of inter-
est were likely, even within a period of incubation as short
as 48 h. The FP strains that were considered for this
study were ultimately placed in one of three categories
of essentiality: conditionally essential, non-essential, and
non-essential with mutations. Those strains that were
repeatedly able to grow given longer periods of incu-
bation were considered non-essential (with or without
mutations) and thus in agreement with model predic-
tions of growth (i.e., reassigned as true positives). Of these
strains, mechanisms of adaptation to genetic perturbation
were categorized broadly as either requiring mutations or
not requiring mutations for growth. Population sequenc-
ing and mutation analysis of the FP KO strains revealed
that 82% (9 out of 11) of the strains that grew accrued
mutations in at least some of the replicate population
samples sequenced (Fig. 1). This result is of general inter-
est as short-term growth screens are commonly practiced
with the assumption that mutations are not acquired dur-
ing such short periods of growth. A set of KO strains
which accrued mutations could be linked directly or indi-
rectly to predicted suppression phenotypes (see below).
For those populations that did not accrue mutations, it
is suggested that the annotated alternate pathways or
isozymes listed in the genome-scale reconstruction and
model of metabolism utilized in this study were likely
correct. However, such confirmation of unmutated KO
strains was not the focus of this study and future work
could examine this more comprehensively by perform-
ing similar additional cellular measures such as expression
analysis of the predicted isozymes, as was shown for a sub-
set of cases here and has been previously demonstrated
[14], or a complementary approach such as ribosomal
sequencing [72]. Furthermore, it is also of general inter-
est to note that some starting Keio strains grown and
isolated on a nutrient rich medium possessed mutations
that may have influenced growth on the minimal medium
(Additional file 5). There is strong evidence for this in the
ptsI KO strain in the Keio collection. Given the wide usage
of such gene-deletion libraries, it is important to under-
stand baseline mutations and how they may influence
downstream applications.
Examination of mutational parallelism at the gene level
proved to be informative and provided compelling contex-
tual evidence for correlation to modeling predictions in a
number of the gene KO cases examined. For those strains
that did require mutations, the mutations observed across
replicate experiments (Table 2) allowed for the identifica-
tion of proposed alternate pathways. Six of the nine cases
examined (thrA, ptsI, proA, proB, metC, and
cysK) showed key mutations that were interpreted to
be in agreement with the model-predicted alternate path-
ways, thus allowing us to label them as newly assigned true
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positives. Mutation enrichment across replicate experi-
ments has been shown to provide strong evidence that
they were positively selected for [23, 24], and this cou-
pled with previously reported data provided the basis for
the proposed mechanisms of adaptation described in this
study. The establishment of causality for each gene KO
strain in detail, however, will require follow-up experi-
ments isolating individual mutants and conducting more
detailed experimental analysis as has been previously
demonstrated [73]. The results and mutations identified
here are the starting point for such studies. Furthermore,
there are additional key mutations which were identified
to display parallel evolution (e.g., metK in the metL
strain) whose mechanism of adaptation was not immedi-
ately obvious and such cases provide additional targets for
discovery (see Table 2).
Conclusions
Adaptive flexibility is critical for organisms evolv-
ing to novel ecological niches or responding to envi-
ronmental stress. When examining gene essentiality
for applications such as drug discovery or modify-
ing industrial bioprocessing strains, one must consider
possible unanticipated adaptive mechanisms that may fol-
low the intended genetic disruption. Underlying enzy-
matic side activities may rise to the surface after short
adaptive periods leading to unwanted ‘rogue’ activi-
ties [74]. This study shows that while high-throughput,
short-term growth screens may capture a large-scale pic-
ture of gene essentiality, they may not reveal underly-
ing metabolic capabilities attainable with slightly longer
incubation or short adaptive periods. Furthermore, these
findings suggest that many of the strains in large gene-
deletion collections, such as the Keio collection, likely
contain adaptive mechanisms to overcome the intended
KOs. Thus, sequencing is likely necessary prior to using
such clones for the myriad applications they enable.
In conclusion, the results presented in this study high-
light genetic and metabolic flexibility in response to
gene disruption in the organism E. coli. Furthermore,
genome-scale reconstructions and metabolic models pro-
vide a promising avenue for the elucidation of adap-
tive mechanisms and for predicting observable in vivo
phenotypes.
Methods
False positives selection and In silicomodel validation
The false positive strains identified for longer growth tests
were taken from the previously published work [13]. The
strains listed in Additional file 1 are the subset of genes
considered in this study. They were described as false pos-
itive predictions on at least one substrate examined and
had no experimental growth on any of 34 substrates exper-
imentally tested [13]. However, upon further examination,
it was observed that cysK and cysP did have exper-
imental evidence of growth on glucose carbon source
[7, 66]. These two cases were thus examined using a glyc-
erol substrate on which they were still considered false
positive predictions [68].
The false positive predictions were verified as growth
predictions in silico by utilizing the comprehensive
metabolic reconstruction of E. coli K-12 MG1655,
iJO1366 [10]. The flux balance analysis (FBA) simulations
were conducted using the constraint-based modeling
package COBRApy [75]. Simulations were conducted by
optimizing the core biomass objective function, which
is determined to be a stoichiometric representation
of all core metabolic biomass components in the cell
[66]. In order to better match the genotype of the
BW25113 Keio Collection parent strain adjustments were
made to the iJO1366 model to reflect missing genes
(araBAD, rhaBAD, and lacZ). Flux through reactions
ARAI, RBK_L1, RMPA, LYX1, RMI, RMK, and LACZ
was constrained by setting reaction bounds to zero as
has been previously performed [10, 12]. To simulate a
gene-deletion growth screen and thereby closely mimic
experimental growth conditions, the desired gene was
removed from the metabolic model and then a FBA sim-
ulation was run as previously described [13], setting the
glucose (or glycerol) exchange reaction lower bound to -
10 mmol · gDW−1h−1 (gDW is an abbreviation of gram
of dry weight) and the oxygen exchange reaction lower
bound to -1000mmol · gDW−1h−1. All gene-deletion sim-
ulations were verified to result in a prediction of growth in
agreement with previous reports [13]. All genes listed in
Additional file 1 were confirmed to be false positives and
FBA simulation results of isozymes and alternate path-
ways are additionally provided for a subset of genes from
Table 1 in Additional file 8.
Isozymes and alternate pathways listed in Table 1 were
determined based on analysis of iJO1366. Isozymes were
extracted from the gene-protein-reaction (GPR) associ-
ations for each reaction in the model, where a Boolean
“OR" relationship indicates a set of isozymes. Alternate
pathways were identified by knocking out a target path-
way responsible for production of an essential biomass
component, running FBA with this pathway knocked out,
and looking for alternative reaction flux that enables
production of the essential biomass component. These
alternative pathways are also present in the EcoCyc knowl-
edge base [76] with the exception of serB (Fig. 2c).
These isozymes and alternate pathways are also listed and
described in a previous publication [13].
Strains utilized and PCR verification
All strains utilized in this study were taken from the
single-gene deletion Keio collection [7]. The strains
examined in this work are listed in Additional file 1.
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These strains are all derived from the parent Keio strain
E. coli K-12 BW25113. The reference strain utilized in
growth screens and wherever ‘wild type’ is specified in this
manuscript is the parent Keio strain without any deletions
or Kanamycin resistance cassette.
The strains utilized in the growth screens were first
verified by polymerase chain reaction (PCR) experi-
ments utilizing the methods detailed in [7]. For each
strain that was used, they were verified by three
PCR reactions utilizing 1)flanking primers, 2) inter-
nal K1 and forward flanking primer, and 3) inter-
nal K2 and reverse flanking primer as previously
suggested in [7].
Culture conditions and growth characterizations
Rich media utilized for pre-culture growth was Luria-
Bertani Broth (LB). LB media consisted of an auto-
claved 25 g/L LB Broth (EMD Millipore LB Broth, Miller
- Novagen, catalog 71753) in Milli-Q water. The M9
minimal media utilized in the long term growth char-
acterizations consisted of 0.1mM CaCl2 , 2mM MgSO4,
1x Trace elements Solution, 1x M9 salts solution, and
either 2g/L glucose or 0.2% (by volume glycerol), in Milli-
Q water. The 4000x trace elements solution consisted of
27 g/L FeCl3 · 6H2O, 1.3 g/L ZnCl2, 2 g/L CoCl2 · 6H2O,
2 g/L Na2MoO4*2H2O, 0.75 g/L CaCl2, 0.91 g/L CuCl2 ·
2H2O, and 0.5 g/L H3BO3, in concentrated HCl. The 10x
M9 salt solution was composed of 68 g/L Na2HPO2, 30
g/L KH2PO2, 5 g/L NaCl, and 10 g/L NH4Cl, in Milli-Q
water. TheM9media, trace elements solution, andM9 salt
solutions were all sterile filtered. Except for the BW25113
wild-type strain, all LB and M9 cultures contained 25
mg/L Kanamycin A.
The twenty strains that were available in the Keio col-
lection and PCR verified (Additional file 1), were selected
for an initial long-term growth test. Pre-cultures of these
strains were grown overnight in 2-3 mLs of LB media
in a 10 mL culture tube on a shaker plate. The fol-
lowing morning, 50 mL M9 minimal media cultures in
250-mL Erlenmeyer flasks containing magnetic stir bars
for aeration were inoculated at a target OD600 of 0.01-
0.02. The OD600 was monitored at least once a day
for two weeks or until growth was observed, at which
point the cells were passed to a new flask of M9 min-
imal media to ensure that the growth observed per-
sisted. The cells were passed consecutively to 5 flasks to
ensure the growth observed was consistent. At the end
of the experiment, glycerol stock samples were frozen
at -80 °C for future use and the flask 5 population was
PCR validated as described above to ensure there was no
contamination.
Following the initial growth screen, a more detailed
growth characterization was conducted on an automated
platform. Initial 15 mL LB pre-cultures were inoculated
from glycerol frozen stocks of the Keio KO Collection
strains and the Keio KO parent strain BW25113, and were
grown overnight. Growth test cultures were then started
in triplicate by pipetting 50 μL from a preculture into
three 17 mL tubes containing M9 minimal media. Both
the pre-cultures and growth tests were grown at 37 °C in
magnetically stirred tubes, at a rate of 1,100 rpm to ensure
full aeration. Optical density at 600 nm (OD600) sam-
pling was performed using an automated system with a
Tecan Sunrise Microplate Reader, using 100 μL of culture
for each measurement. Sampling frequency was initially
between 6-12 h, and was increased to 2-4 h once growth
was observed. The OD600 data was then converted to
units of grams of dry weight per liter (gDW/L) using the
conversion factor for the plate reader and sample vol-
ume (1.663 gDW/L/OD600). The growth curves depicted
in Fig. 1b were constructed by importing cell density
data from the experiment into a Jupyter notebook (http://
jupyter.org/) and utilizing the scientific computing library
suite SciPy (http://www.scipy.org/).
Whole genome sequencing andmutation analysis
Genomic DNA was isolated using a Macherey-Nagel
NucleoSpin Tissue Kit. DNA concentrations were deter-
mined using a Thermo Fischer Qubit dsDNA HS Assay
Kit. Paired-end whole genome DNA sequencing libraries
were prepared using a Kapa Biosystems KAPA Hyper-
Plus Kit.Manufacturer protocols were followed for all kits.
DNA sequencing libraries were then run on a Illumina
HiSeq4000 platform with a 100/100 HiSeq 3000/4000 PE
cycle kit (PE-410-1001).
The breseq pipeline [77] version 0.30.0 with bowtie2
version 2.2.6 [78] was used to map sequencing reads
and identify mutations relative to the E. coli BW25113
genome (NCBI accession CP009273.1). For the samples
examined in this study, the average of percent mapped
reads was 95% and average mean coverage was 130
reads. The pre-existing mutations observed in the knock-
out strains prior to growth characterization experiments
(compared to the wild type BW25113 reference strain)
are provided in Additional file 5. Mutations considered
for analysis in this study were present in a population
at a fraction > 0.2. Those mutations listed in Table 2,
were further filtered so the key mutations discussed in
the results are presented. The complete list of mutations
observed above the population fraction cut-off is pro-
vided in Additional file 4. Additionally, analysis of large
regions of genome duplication was performed by ana-
lyzing read depth coverage utilizing a custom python
script. Contingency table analysis shown in Additional
file 3 running Fisher’s exact tests were conducted using
conducted using the scientific computing Python library
SciPy (http://www.scipy.org/) in a Jupyter Notebook
(http://jupyter.org/).
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RNA sequencing
RNA sequencing data were generated under aerobic,
exponential growth conditions on M9 minimal medium
plus 2 g/L D-glucose and 50 mg/L Kanamycin A. The wild
type BW25113 strain control was grown in the absence
of antibiotics. Culture conditions and growth conditions
were the same as those used in the automated charac-
terizations described above. Pre-cultures for the RNA
sequencing experiments were taken by scraping frozen
stocks (taken from the growth characterization experi-
ments) and growing all strains in M9 minimal medium
plus 2 g/L D-glucose. The pre-cultures were split into
two 17 mL tubes (biological duplicates) for each exper-
imental condition. Cells were harvested in exponential
growth using the Qiagen RNA-protect bacteria reagent
according to the manufacturer’s specifications. Pelleted
cells were stored at -80 C prior to RNA extraction. Cell
pellets were thawed and incubated with lysozyme, Supera-
seIN, protease K, and 20% sodium dodecyl sulfate for
20 min at 37 C. Total RNA isolation and purification
was performed using Qiagen’s RNeasy minikit column
according to the manufacturer’s specifications. After total
RNA isolation, its quality was checked with the Agilent
Bioanalyzer using their RNA 6000 nano kit. Ribosomal
RNA (rRNA) was removed using Epicentre’s Ribo-Zero
rRNA removal kit for Gram-negative bacteria. Paired-
end, strand-specific RNA sequencing libraries were gen-
erated using Kapa Biosystem’s KAPA RNAHyperPrep Kit.
The final pool of libraries was subjected to a 1x SPRI
(Solid Phase Reversible Immobilization) bead size selec-
tion to further remove unincorporated PCR primers. RNA
sequencing libraries were run on an Illumina NextSeq 550
machine using a NextSeq 500/550 Mid Output v2 kit (150
cycles).
For each condition examined, biological duplicate
samples were sequenced and analyzed. RNA sequencing
reads were mapped to the E. coli BW25113 genome
(CP009273.1) using bowtie2 version 2.3.4.1 [78] and the
following options: bowtie2 -X 1000 -N 1 -p 20
-3 3 -1 <R1 files> -2 <R2 files> -x <
index>. The SAM output file of bowtie2 was converted
to BAM and sorted using samtools version 1.8 [79]. The
average total number of reads per sample was 9.8 million
reads, with the minimum number of reads for one sample
being 6.8 million reads and the maximum number of
reads for one sample being 17 million reads. All samples
had an alignment rate greater than 97.5%. The read
counts per gene for each sample were calculated using
the summarizeOverlaps function from the R package
GenomicAlignments in Bioconductor. The input options
for the summarizeOverlaps function were as follows:
mode=“Union”, singleEnd=FALSE, ignore.strand=FALSE,
fragments=FALSE. The raw counts calculated by the
summarizeOverlaps function were used to identify
differentially expressed genes using the DESeq and results
functions from the R package DESeq2 in Bioconductor.
The results function extracted log2(fold change) data
and p-adjusted values from the DESeq analysis allowing
for comparison of the experimental condition expres-
sion data (biological duplicate replicates) to wild type
BW25113 expression data (biological duplicate repli-
cates). The p-adjusted values used to construct Fig. 3
and displayed in Table 3 accounted for multiple testing
correction using the Benjamini and Hochberg method,
which is the default “BH" option for the DESeq2 results
function. The independent filtering option for the results
function was set to FALSE to obtain p-adjusted values for
all genes. Gene expression fold changes were considered
significant if the log2(fold change) was greater than 1 and
the calculated p-adjusted value was smaller that 0.05.
Volcano plots were constructed for the serB and thrA
experiments (Fig. 3) in a Jupyter Notebook using (http://
jupyter.org/) and the Python plotting library Matplotlib
[80]. The RNAseq data is available in the Gene Expression
Omnibus (GEO) database under the accession number
GSE117303.
Additional files
Additional file 1: All FP KO strains considered in this study. This file (.pdf)
contains a table listing all false positive KO strains considered for extended
growth tests. Additional information regarding proposed conditional
essentiality is also provided as well as a comparison to a previous study
[22]. (PDF 67 kb)
Additional file 2: Growth curves of five false positive replicate strains (ptsI,
serB, proA, proB, and carA) in separate subplots are displayed. This file (.pdf)
contains a figure that is an extension of Figure 1B, as the same curves for
these cases are displayed; however, specific labeling of each curve with
their associated experiment (exp.) number is provided in the legend of
each subplot. The experiment number corresponds to those numbers
listed in Table 2. (PDF 183 kb)
Additional file 3: Contingency table examples showing the likelihood of
mutational convergence. This file (.pdf) contains a figure of contingency
table examples showing the likelihood of mutational convergence
between two samples. p-values calculated from Fisher’s exact test are
reported for four examples. (PDF 97 kb)
Additional file 4: Mutations Summary for each FP case. This file (.xlsx)
contains all mutations found for each false positive case described in this
study. (XLSX 52 kb)
Additional file 5: Mutations observed in starting strains grown in LB rich
medium. This file (.pdf) contains a table listing mutations identified in the
PCR-confirmed Keio strains that were used in the extended growth tests
on minimal medium. (PDF 49 kb)
Additional file 6: Secondary structure of tRNAHis and observed hisR
mutations. This file (.pdf) contains a figure showing the secondary structure
of tRNAHis and observed hisR mutations aligned with tRNA numbering
convention. (PDF 272 kb)
Additional file 7: Genome duplication amplification events observed in
cysK, carA, and ptsI experiments. This file (.pdf) contains a figure showing
the read depth coverage (y-axis) plotted against the genome position
(x-axis) for flask 1 population samples for A. cysK, B. carA, C. and ptsI
experiments. (PDF 316 kb)
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Additional file 8: FBA simulations for genes listed in Table 1. This file (.pdf)
contains a table of simulations demonstrating the same predicted behavior
in both the iJO1366 model corresponding to the MG1655 genotype and a
modified iJO1366 model corresponding to the BW25113 genotype.
(PDF 79 kb)
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